Top results

Things to Know About Medication Interactions With Atypical Antipsychotics

This patient resource presents an overview of drug-drug interactions for patients taking medications for psychiatric conditions, with a focus on the role of open and clear communication with the care team. It encourages patients to share a complete and up-to-date medication history so potential interaction risks can be identified and managed.

Download PDF

Recommended on NP Psych Navigator

Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

Clinical Article

Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial was a 7-year nationwide clinical trial designed to evaluate the efficacy of different medications in patients who did not respond to an initial antidepressant. Rush et al. (2006) evaluated acute and long-term treatment outcomes in patients who participated in the STAR*D trial and identified differences in response and remission rates and time to remission across patients who received up to four sequential treatment steps.
Child Mania Rating Scale – Parent Version (CMRS-P)

Psychiatric Scales

Child Mania Rating Scale – Parent Version (CMRS-P)

The Child Mania Rating Scale–Parent Version (CMRS-P) is a parent-report rating scale designed to assess manic symptoms in children and adolescents.1 Adapted from Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-4) criteria for mania, the CMRS-P provides a reliable and validated method to differentiate pediatric mania from attention-deficit hyperactivity disorder (ADHD).1,2
Pediatric Positive and Negative Syndrome Scale (Kiddie-PANSS)

Psychiatric Scales

Pediatric Positive and Negative Syndrome Scale (Kiddie-PANSS)

The Kiddie Positive and Negative Syndrome Scale (Kiddie-PANSS) is a 30-item clinician-rated instrument adapted from the adult PANSS to evaluate schizophrenia symptom severity in children and adolescents. It is designed to assess the severity of positive, negative, and general psychopathology symptoms in pediatric schizophrenia spectrum disorders. It modifies item wording and administration methods for developmental appropriateness.1
SF-12 Health Survey (SF-12v2)

Psychiatric Scales

SF-12 Health Survey (SF-12v2)

The SF-12 Health Survey version 2 is a brief, 12-item questionnaire designed to measure overall physical and mental health status across 8 domains.  

Welcome To NP Psych Navigator

This website is intended for healthcare professionals inside the United States.
Please confirm that you are a healthcare professional inside the US.

No, I am not US Healthcare professional

You are now leaving NP Psych Navigator

Links to sites outside of NP Psych Navigator are provided as a resource to the viewer. AbbVie Inc accepts no responsibility for the content of non-AbbVie linked sites.

Redirect to: